Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease
Florian Kronenberg, MD*,
Markus Stühlinger, MD ,
Evi Trenkwalder, PhD*,
F. S. Geethanjali, PhD ,
Otmar Pachinger, MD,
Arnold von Eckardstein, MD and
Hans Dieplinger, PhD*
* Institute of Medical Biology and Human Genetics, University of Innsbruck, Innsbruck, Austria
Innsbruck University Hospital, Department of Cardiology, Innsbruck, Austria
Department of Clinical Biochemistry, Christian Medical College and Hospital, Vellore, India
Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Universität Münster, Münster, Germany
View larger version (26K):
[in a new window]
|
Figure 1 Distribution of apolipoprotein A-IV (apoA-IV) plasma concentrations in patients with coronary artery disease and controls. Panel A shows the results of 114 Caucasian male patients and 114 male controls. Panel B describes the apoA-IV distribution in 68 male Asian Indian patients and 68 age-matched male controls.
|
|
View larger version (16K):
[in a new window]
|
Figure 2 Correlation between plasma concentrations of apolipoprotein A-IV (apoA-IV) and high-density lipoprotein (HDL) cholesterol in Caucasian controls (panel A) and Caucasian patients (panel B).
|
|
View larger version (16K):
[in a new window]
|
Figure 3 Odds ratio (OR) and 95% confidence interval (CI) as an approximation of the relative risk a patient with coronary artery disease in case of low or high plasma concentrations of apolipoprotein A-IV (apoA-IV) and HDL cholesterol (panel A) and in case of low or high plasma concentrations of apoA-IV and triglycerides (TG) (panel B). The median levels of these variables from the control group were used as categorization cutpoints. Arrows provide the relative increase of the odds.
|
|
|
